Lisanti Capital Growth LLC purchased a new stake in Planet Labs PBC (NYSE:PL – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 105,030 shares of the company’s stock, valued at approximately $2,071,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. AQR Capital Management LLC increased its stake in shares of Planet Labs PBC by 671.1% during the 1st quarter. AQR Capital Management LLC now owns 92,693 shares of the company’s stock worth $313,000 after purchasing an additional 80,672 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Planet Labs PBC in the 1st quarter valued at about $189,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Planet Labs PBC by 6.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 130,798 shares of the company’s stock worth $442,000 after purchasing an additional 8,143 shares during the period. Goldman Sachs Group Inc. grew its holdings in Planet Labs PBC by 54.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,856,245 shares of the company’s stock worth $6,274,000 after purchasing an additional 653,173 shares during the period. Finally, Thompson Davis & CO. Inc. acquired a new position in Planet Labs PBC during the second quarter worth approximately $121,000. Institutional investors own 41.71% of the company’s stock.
Insider Buying and Selling at Planet Labs PBC
In related news, insider Robert H. Schingler sold 73,683 shares of the business’s stock in a transaction on Monday, April 6th. The stock was sold at an average price of $35.07, for a total value of $2,584,062.81. Following the completion of the sale, the insider directly owned 256,488 shares in the company, valued at $8,995,034.16. The trade was a 22.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ashley F. Johnson sold 200,000 shares of the company’s stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $35.10, for a total value of $7,020,000.00. Following the completion of the transaction, the chief financial officer directly owned 1,895,162 shares in the company, valued at approximately $66,520,186.20. This represents a 9.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 17.53% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Report on PL
Planet Labs PBC Trading Up 4.5%
Shares of NYSE:PL opened at $44.39 on Friday. Planet Labs PBC has a 12-month low of $3.53 and a 12-month high of $45.78. The stock has a market cap of $15.36 billion, a PE ratio of -56.91 and a beta of 1.91. The business has a 50 day moving average of $35.37 and a 200-day moving average of $25.30. The company has a quick ratio of 1.64, a current ratio of 1.65 and a debt-to-equity ratio of 2.37.
Planet Labs PBC Company Profile
Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.
Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.
Recommended Stories
- Five stocks we like better than Planet Labs PBC
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding PL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Planet Labs PBC (NYSE:PL – Free Report).
Receive News & Ratings for Planet Labs PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Planet Labs PBC and related companies with MarketBeat.com's FREE daily email newsletter.
